COMP <GO>
AVTR vs UNH // NET PROFIT MARGIN
Avantor Inc. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: AVTR 1
— UNH 13
▲ NET PROFIT MARGIN LEADER: UNH
LAST: $16.05 (-3.78%) • MKT CAP: $11.30B
net-margins
-8.10%
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
net-margins
3.14%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AVTR VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AVTR | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 32.70% | 88.57% | -55.87 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -2.10% | 11.47% | -13.57 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 16.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.38% | 6.48% | -2.10 | UNH | /fcf-yield <GO> |
| Operating Margin | -3.80% | 4.82% | -8.62 | UNH | /operating-margins <GO> |
| Net Profit Margin ACTIVE | -8.10% | 3.14% | -11.24 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | -3.40% | 6.46% | -9.86 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.88 | 3.12 | -1.24 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.90% | 6.74% | +0.16 | UNH | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.1 | 56.0 | -6.95 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.01 | 0.33 | +0.68 | AVTR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 31.0x | 17.1x | +13.91 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $11.30B | $364.66B | -$353.36B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AVTR REV | UNH REV | AVTR GROSS % | UNH GROSS % | AVTR FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $6.55B | $447.57B | 32.7% | 88.7% | $495.0M | $16.07B |
| FY 2024 | $6.78B | $400.28B | 33.6% | 88.3% | $692.0M | $20.70B |
| FY 2023 | $6.97B | $371.62B | 44.0% | 89.6% | $556.5M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AVTR // BETA 1.01
UNH // BETA 0.33